Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Wharton's jelly mesenchymal stem cell conditioned medium + platelet-rich plasma vs liposomal formulation for androgenetic alopecia
IRCT20200127046282N24Phase 2Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Feb 2023
- Modality
- Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 2 trial of Wharton's Jelly Mesenchymal Stem Cell Conditioned Medium and platelet-rich plasma in androgenetic alopecia (AGA) (2 arms), sponsored by Tehran University of Medical Sciences. Started Feb 2023; status: completed.
02
Drugs
Wharton's Jelly Mesenchymal Stem Cell Conditioned Mediumplatelet-rich plasma
03
Conditions
androgenetic alopecia (AGA)
Beyond the preview
Go deeper on IRCT20200127046282N24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20200127046282N24.